05/01/2026
The FDA may soon be banning compound pharmacies from manufacturing compounds with & .
There are numerous red flags when using a
🚩quality issues
🚩dosing concerns
đźš© fraudulent compounds
đźš© unknown compounds developed by combining with B12
Using a is much safer and more effective at helping you achieve your with educating you with the tools for success!
FDA is proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound these drugs from bulk substances.